508 related articles for article (PubMed ID: 18220793)
1. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
Sharma MC; Sharma M
Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
[TBL] [Abstract][Full Text] [Related]
3. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
Sharma MR; Rothman V; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
[TBL] [Abstract][Full Text] [Related]
4. Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers.
Sharma MC
Int J Cancer; 2019 May; 144(9):2074-2081. PubMed ID: 30125343
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation.
Sharma M; Ownbey RT; Sharma MC
Exp Mol Pathol; 2010 Apr; 88(2):278-86. PubMed ID: 20079732
[TBL] [Abstract][Full Text] [Related]
6. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
7. Annexin II: a plasminogen-plasminogen activator co-receptor.
Kim J; Hajjar KA
Front Biosci; 2002 Feb; 7():d341-8. PubMed ID: 11815288
[TBL] [Abstract][Full Text] [Related]
8. Role of annexin II tetramer in plasminogen activation.
Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
[TBL] [Abstract][Full Text] [Related]
9. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation.
Semov A; Moreno MJ; Onichtchenko A; Abulrob A; Ball M; Ekiel I; Pietrzynski G; Stanimirovic D; Alakhov V
J Biol Chem; 2005 May; 280(21):20833-41. PubMed ID: 15788416
[TBL] [Abstract][Full Text] [Related]
10. Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model.
Sharma M; Blackman MR; Sharma MC
Exp Mol Pathol; 2012 Feb; 92(1):175-84. PubMed ID: 22044461
[TBL] [Abstract][Full Text] [Related]
11. [Structure and functions of plasminogen/plasmin system].
Aĭsina RB; Mukhametova LI
Bioorg Khim; 2014; 40(6):642-57. PubMed ID: 25895360
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of plasmin generation by S100A10.
Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
[TBL] [Abstract][Full Text] [Related]
13. Annexin II: a mediator of the plasmin/plasminogen activator system.
Hajjar KA; Krishnan S
Trends Cardiovasc Med; 1999 Jul; 9(5):128-38. PubMed ID: 10639727
[TBL] [Abstract][Full Text] [Related]
14. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.
Díaz VM; Hurtado M; Thomson TM; Reventós J; Paciucci R
Gut; 2004 Jul; 53(7):993-1000. PubMed ID: 15194650
[TBL] [Abstract][Full Text] [Related]
15. The role of plasminogen-plasmin system in cancer.
Kwaan HC; McMahon B
Cancer Treat Res; 2009; 148():43-66. PubMed ID: 19377918
[TBL] [Abstract][Full Text] [Related]
16. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
[TBL] [Abstract][Full Text] [Related]
17. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
Bharadwaj AG; Kempster E; Waisman DM
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer.
Sharma MC; Tuszynski GP; Blackman MR; Sharma M
Cancer Lett; 2016 Apr; 373(1):27-35. PubMed ID: 26797420
[TBL] [Abstract][Full Text] [Related]
19. From plasminogen to plasmin: role of plasminogen receptors in human cancer.
Didiasova M; Wujak L; Wygrecka M; Zakrzewicz D
Int J Mol Sci; 2014 Nov; 15(11):21229-52. PubMed ID: 25407528
[TBL] [Abstract][Full Text] [Related]
20. Herpesviruses enhance fibrin clot lysis.
Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]